Eliquis®, also known as apixaban, is an oral anticoagulant/blood thinner that’s only been on the market since 2012. It was brought to life under an aggressive advertising campaign which touted the drug’s supposed claim of being a superior alternative to warfarin (Coumadin) due to a lack of regular, necessary blood tests, diet limitations, and complicated dosing requirements. Due to this campaign, unsurprisingly, Eliquis® quickly became popular with doctors, making over $774 million in 2014.
New information, however, is now uncovering grim evidence suggesting that the drug wasn’t tested properly and that its manufacturers, Bristol-Meyers Squibb and Pfizer Inc., withheld necessary information regarding the testing results and the lack of an available antidote. More than one Eliquis® internal bleeding class action lawsuit has now been filed across the U.S. by patients who have taken Eliquis® and suffered from symptoms which resulted in uncontrollable bleeding and deep vein thrombosis.
What is Eliquis and why is it potentially dangerous?
Eliquis® (apixaban) is one of the newest oral anticoagulants (blood thinners) on the market and is used to reduce the risk of blood clots and stroke in patients undergoing knee/hip replacement surgery or with heart or blood conditions like atrial fibrillation (abnormal heart rhythm). Older anticoagulants like warfarin (Coumadin or Jantoven) require patient-specific dosing, regular monitoring, and a special diet, but none of these requirements are advertised as being needed when taking Eliquis.
Similar to other, newer anticoagulants like Xarelto® (rivaroxaban) and Pradaxa® (dabigatran etexilate), Eliquis® works by interrupting the blood-clotting process by blocking Factor Xa enzymes which allow blood clots to form. Because the new anticoagulants work differently than older blood thinners, there is no way to reverse the anticoagulation process once the drug is in a patient’s system. With drugs like warfarin, if a patient begins bleeding uncontrollably, a Vitamin K antidote can be given which stops the blood from continuing to thin. There is no such antidote with Xarelto®, Pradaxa®, or Eliquis®.
All anticoagulants can potentially cause serious side effects. The most serious side effects of Eliquis® in particular include:
- Uncontrollable bleeding (hemorrhage)
- Internal bleeding, including gastrointestinal (GI) bleeding
- Hemorrhagic stroke (brain bleed)
- Deep vein thrombosis (DVT)
- Blood clots
- Bruising more easily
- Skin rash
One of the most dangerous side effects of taking Eliquis® or any type of anticoagulant is the possibility of experiencing a hemorrhage (uncontrollable bleed). In some cases, extreme internal bleeding or hemorrhaging can lead to death. The fact that there isn’t a way to reverse the bleeding process while taking Eliquis® makes it more dangerous than other types of anticoagulants like warfarin.
Why are Eliquis® lawsuits being filed?
While excessive bleeding is always a potential side effect of any anticoagulant, Eliquis® in particular was advertised as being safer than other alternatives. It wasn’t until September 2015 that the FDA required Bristol-Meyers Squibb and Pfizer Inc. to change the warning labels on the drug, making consumers and doctors more aware the severity of the associated bleeding complications. Bristol-Meyers Squibb and Pfizer Inc. didn’t even disclose the fact that Eliquis® doesn’t have an antidote during the drug’s original advertising campaign.
Multiple lawsuits across the United States have been filed against Bristol-Meyers Squibb and Pfizer Inc. stating that the company failed to disclose information regarding the severity of bleeding-related complications and the fact that an antidote doesn’t exist. Additionally, there is further evidence which suggests the company may not have disclosed all the facts from the drug’s clinical trials held back in 2012—including information about the side effects and the fact that one unreported death occurred.
Further evidence suggests that an FDA reviewer didn’t agree with the results of the clinical trials conducted by Bristol-Meyers Squibb and Pfizer Inc. The trial’s results were even delayed by a period of nine months. Other suspicions raised in more than one Eliquis lawsuit question the accuracy of the clinical trial results, stating that different copies of the report point to completely different statistics.
All of this evidence is currently being investigated in a Kentucky lawsuit filed in February 2016. Louisville products liability lawyer Tad Thomas of Thomas Law Offices is serving as counsel for this case and is more than happy to speak to anyone regarding any personal experiences they have had with the drug or its side effects.
What are my legal options?
Major pharmaceutical corporations like Bristol-Meyers Squibb and Pfizer Inc. need to do everything in their power to ensure drugs they release on the market are safe for patients. From the way the evidence is looking so far, the company might be intentionally hiding information and test results in order to increase the amount of profit made from Eliquis®. Legal experts anticipate that hundreds or perhaps even thousands of Americans might have a solid legal case against the drug’s manufacturers.
If you or someone you love has suffered from uncontrollable bleeding or other side effects which may have been caused by taking Eliquis®, your family has a right to file an Eliquis® internal bleeding class action lawsuit against Bristol-Meyers Squibb and Pfizer Inc. Pharmaceutical corporations need to prioritize the health of their customers. Give Louisville drug injury lawyer Tad Thomas a call today to see how he can fight for your right to have access to accurate, publicly-disclosed information regarding the products our lives depend on.